TITLE

Improvement of Functional Recovery of Donor Heart Following Cold Static Storage with Doxycycline Cardioplegia

AUTHOR(S)
Ozcinar, Evren; Okatan, Esma; Tuncay, Erkan; Eryilmaz, Sadik; Turan, Belma
PUB. DATE
March 2014
SOURCE
Cardiovascular Toxicology;Mar2014, Vol. 14 Issue 1, p64
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Injury to the donor heart during cold preservation has a negative impact on graft survival before transplantation. This study aims to examine whether doxycycline, known as an MMP-2 inhibitor, has a positive effect on donor heart preservation via its antioxidant action when added to standard preservation solution. Hearts were obtained from 3-month-old male Wistar rats and randomly divided into three groups: hearts stored for 1 h at 4 °C (1) with doxycycline preservation solution (DOX cardioplegia) with low Ca; (2) with standard cardioplegia with low Ca; and (3) unstored hearts. All hearts were perfused in working mode, arrested at 37 °C, removed from the perfusion system, reattached in Langendorff perfusion system, and converted to working mode for 1 h. At the end of the storage period, hearts preserved in DOX cardioplegia had significantly less weight gain than those preserved in the standard cardioplegia. DOX cardioplegia-induced preservation resulted in significantly higher heart rates and better recovery quality during reperfusion in aortic flow compared to the standard cardioplegia group. Recovery in the left ventricular function and Lambeth Convention Arrhythmia scores during 1 h reperfusion were also significantly better in the DOX cardioplegia group. Biochemical data showed that DOX cardioplegia prevented an increase in MMP-2 activity and blocked apoptosis through increased activity of the pro-survival kinase Akt in the donor heart homogenates. DOX cardioplegia also led to a balanced oxidant/antioxidant level in the heart homogenates. This is the first study to report that cardioplegia solution containing doxycycline provides better cardioprotection via the preservation of heart function, through its role in controlling cellular redox status during static cold storage.
ACCESSION #
94667368

 

Related Articles

  • Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR. Antonio, Raquel; Ceron, Carla; Rizzi, Elen; Coelho, Eduardo; Tanus-Santos, Jose; Gerlach, Raquel // Molecular & Cellular Biochemistry;Jan2014, Vol. 386 Issue 1/2, p99 

    Increased matrix metalloproteinase (MMP) levels are involved in vascular remodeling of hypertension. In this study, we hypothesized that doxycycline (a MMP inhibitor) could exert antioxidant effects, reverse establish vascular remodeling, and lower blood pressure in spontaneously hypertensive...

  • Associated factors with survivals in patients undergoing orthotopic heart transplant using retrograde blood microcardioplegia. Ramos Lavagnoli, Carlos Fernando; de Oliveira Severino, Elaine Soraya Barbosa; de Souza Vilarinho, Karlos Alexandre; da Mota Silveira Filho, Lindemberg; de Oliveira, Pedro Paulo Martins; Petrucci, Orlando; Wilson Vieira, Reinaldo; Marcolino Braile, Domingo // Brazilian Journal of Cardiovascular Surgery;jul-set2012, Vol. 27 Issue 3, p347 

    Background: Several techniques and cardioplegic solutions have been used for heart preservation during transplant procedures. Unfortunately, there is a lack of ideal method for myocardial preservation in the clinical practice. The use of retrograde cardioplegia provides continuous infusion of...

  • Adenosine injection prior to cardioplegia enhances preservation of senescent hearts in rat heterotopic heart transplantation. Hyun Lim, Sang; Lee, Sungsoo; Noda, Kentaro; Kawamura, Tomohiro; Tanaka, Yugo; Shigemura, Norihisa; Nakao, Atsunori; Toyoda, Yoshiya // European Journal of Cardio-Thoracic Surgery;Jun2013, Vol. 43 Issue 6, p1202 

    OBJECTIVES Advanced donor age is one of the risk factors for graft failure and is the leading cause of early death after heart transplantation. Better myocardial preservation methods should reduce graft failure. The purpose of this study was to determine if adenosine, which is known to enhance...

  • Optimizing cardioplegia strategy for donor hearts. Johnson, Charles E.; Faulkner, Sherry C.; Tucker, Juan; Schmitz, Michael L.; Mee, Roger B. B.; Drummond-Webb, Jonathan J. // Perfusion;Jan2004, Vol. 19 Issue 1, p65 

    Variability in organ preservation strategy has thus far prevented meaningful analysis of clinical donor heart cardioplegia strategies. This paper describes our donor heart procurement protocol, techniques, and recovery team responsibilities. We present 21 patients receiving cardiac...

  • BJCVS on social networks. BRAILE, Domingo M. // Brazilian Journal of Cardiovascular Surgery;jan-mar2012, Vol. 27 Issue 1, pi 

    An introduction is presented in which the editor discusses various articles within the issue on topics including a scientometric index to balance the participation of the first author in publications, cardiac transplantation using retrograde blood microcardioplegia and transcatheter implant.

  • Reanimating Retired Organs.  // Popular Science;Dec2008, Vol. 273 Issue 6, p61 

    The article discusses a heart transplanting technique being developed by Doris Taylor, a biologist at the University of Minnesota. She has found that putting a live rat's cells into a donated rat's heart can regenerate the heart and make it begin beating again. She plans to begin testing this...

  • Melatonin causes regression of endometriotic implants in rats by modulating angiogenesis, tissue levels of antioxidants and matrix metalloproteinases. Yilmaz, Bulent; Kilic, Sevtap; Aksakal, Orhan; Ertas, Ibrahim; Tanrisever, Gonca; Aksoy, Yasemin; Lortlar, Nese; Kelekci, Sefa; Gungor, Tayfun // Archives of Gynecology & Obstetrics;Jul2015, Vol. 292 Issue 1, p209 

    Purpose: The aim of this study was to test if melatonin causes regression of endometriotic implants and whether it influences implant levels of superoxide dismutase (SOD), malondialdehyde (MDA), vascular endothelial growth factor (VEGF), tissue inhibitor of metalloproteinase (TIMP)-2 and matrix...

  • Preclinical evaluation of coronary vascular function after cardioplegia with HTK and different antioxidant additives Schröder, Cornelia; Heintz, Anke; Pexa, Annette; Rauen, Ursula; Deussen, Andreas // European Journal of Cardio-Thoracic Surgery;May2007, Vol. 31 Issue 5, p822 

    Abstract: Objective: Due to limited resources, improvement of preservation solutions is still of great importance in cardiac transplant surgery. New additives with antioxidant properties were tested with respect to coronary function of isolated rat hearts. Methods: Bretschneider HTK solution...

  • 31P MRS of heart grafts provides metabolic markers of early dysfunction. Caus, Thierry; Kober, Frank; Mouly-Bandini, Annick; Riberi, Alberto; Métras, Dominique R.; Cozzone, Patrick J.; Bernard, Monique // European Journal of Cardio-Thoracic Surgery;Oct2005, Vol. 28 Issue 4, p576 

    Abstract: Objective: Early graft failure (EGF) is a life-threatening event still accounting for a significant percentage of early deaths after heart transplantation. We tested whether selected metabolic markers, including high-energy phosphate concentrations measured ex vivo in pre-transplant...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics